stroke. Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Intervention 1: Intervention group: cathodal. It includes ten sessions of routine stroke physiotherapy along with cathodal TDCS. In this study, the TDCS device (ActivaDose® II, ActivaTeK™ Inc., Gilro
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Stroke patients with an age range of 40 to 80 years At least 6 months have passed since the stroke No history of botulism injections or other invasive treatments in the past 6 months The minimum Ashworth score is 1.
Exclusion criteria
Exclusion criteria: History of epilepsy History of cerebellar aneurysm Metal implants in the brain Widespread infection (all areas of the middle cerebral artery) Severe flaccid hemiplegia head injury Other neurological or orthopedic diseases that can affect motor function Renal or hepatic impairment Report of injection of previous painkillers Severe cognitive impairment The stroke areas involve both hemispheres
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The grade of spasticity in ankle plantar flexor muscles during active and passive ankle dorsiflexion. Timepoint: Before intervention, after the tenth session of the intervention, two weeks after the last session of the intervention. Method of measurement: Modified Ashworth scale and electromyography device.;Balance. Timepoint: Before intervention, after the tenth session of the intervention, two weeks after the last session of the intervention. Method of measurement: Berg balance scale.;Quality of life. Timepoint: Before intervention, after the tenth session of the intervention, two weeks after the last session of the intervention. Method of measurement: WHOQOL-BREF. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Ehsani
Semnan University of Medical Sciences
Outcome results
None listed